The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: Role of heparan sulfate proteoglycans and apolipoprotein E

Journal of Bone and Mineral Research

Volumn 17, Issue 3, 2002, Pages 426-433

  Newman, Paul ^a,b   Bonello, Fiona ^a   Wierzbicki, Anthony S ^a   Lumb, Peter ^a   Savidge, Geoffrey F ^a   Shearer, Martin J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apolipoprotein E; Heparin; Lipoproteins; Osteoblasts; Vitamin K

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; HEPARIN; HEPARIN LYASE; LIPOPROTEIN; OSTEOCALCIN; PHYTOMENADIONE; PROTEOHEPARAN SULFATE;

ARTICLE; BONE DENSITY; BONE MATRIX; BONE MINERAL; CARBOXYLATION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOPOROSIS; PROTEIN TRANSPORT; VITAMIN METABOLISM;

APOLIPOPROTEINS E; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CHLOROQUINE; CHYLOMICRONS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HEPARIN LYASE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; OSTEOBLASTS; VITAMIN K 1;

EID: 0036180589     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.3.426     Document Type: Article

References (49)

1. Vitamin K dependent modifications of glutamic acid residues in prothrombin
2. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin
3. Direct identification of the calcium-binding amino acid γ-carboxyglutamate in mineralized tissue
4. Matrix Gla Protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone
5. Vitamin K nutrition and osteoporosis
6. Role of vitamin K in bone metabolism
7. The roles of vitamins D and K in bone health and osteoporosis prevention
8. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
9. Cellular signalling by lipoprotein receptors
10. 1) in humans
11. Transport of vitamin K to bone in humans
12. Hepatic uptake of chylomicron remnants
13. Heparin effect on bone density
14. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
15. 3, parathyroid hormone and glucocorticoids
16. The isolation and culture of cells from explants of human trabecular bone
17. New aspects on heparin and lipoprotein metabolism
18. Treatment of venous thromboembolism
19. Chylomicron and chylomicron remnant catabolism
20. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans
21. Chylomicron metabolism: Chylomicron uptake by bone marrow in different animal species
22. Lipoprotein lipase reduces secretion of apolipoprotein E from macrophages
23. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects
24. Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones
25. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
26. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages
27. Familial dysbetalipoproteinemia: Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits and cows
28. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
29. Type III hyperlipoproteinemia: Defective metabolism of an abnormal apolipoprotein E
30. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
31. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects
32. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations
33. Phylloquinone transport and its influence on γ-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis
34. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
35. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
36. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin
37. Bone health of adult hemodialysis patients is related to vitamin K status
38. Association of bone mineral density with apolipoprotein E phenotype
39. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype
40. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk-The study of osteoporotic fractures
41. Heparin enhancement of factors stimulating bone resorption in tissue culture
42. Heparin augments osteoclast resorption-stimulating activity in serum
43. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
44. Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones
45. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins
46. Interaction of lipoprotein lipase with heparin
47. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: Roles for low density lipoprotein receptors and heparan sulfate proteoglycans
48. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin
49. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria